{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:13:41Z","timestamp":1788430421259,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015502","name":"Dialysis Clinic Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ekir.2026.106686","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:46:30Z","timestamp":1782852390000},"page":"106686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hydrocortisone Use for Septic Shock in Patients With CKD"],"prefix":"10.1016","volume":"11","author":[{"given":"Parth","family":"Dhamelia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashane","family":"Abeyagunawardene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajshekhar A.","family":"Kore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninad","family":"Khandekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishank","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106686_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.106686_bib2","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.ekir.2026.106686_bib3","article-title":"Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials","volume":"43","author":"Singh","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ekir.2026.106686_bib4","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106686_bib5","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1001\/jama.2017.13836","article-title":"Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014","volume":"318","author":"Rhee","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106686_bib6","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106686_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/srep10539","article-title":"Chronic kidney disease is associated with a higher 90-day mortality than other chronic medical conditions in patients with sepsis","volume":"5","author":"Mansur","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106686_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2215\/CJN.0000000861","article-title":"Sepsis-related hospitalization and mortality in patients with CKD","volume":"21","author":"Khandekar","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106686_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106686_bib10","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1073\/pnas.91.2.752","article-title":"Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor","volume":"91","author":"Ray","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2026.106686_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/toxins12050300","article-title":"Chronic kidney disease-associated immune dysfunctions: impact of protein-bound uremic retention solutes on immune cells","volume":"12","author":"Espi","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ekir.2026.106686_bib12","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ekir.2026.106686_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fendo.2016.00070","article-title":"The role of ACTH and corticosteroids for sepsis and septic shock: an update","volume":"7","author":"Annane","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ekir.2026.106686_bib14","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis Campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ekir.2026.106686_bib16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106686_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1016\/j.ekir.2026.106686_bib18","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1038\/s41467-025-59616-2","article-title":"Effectiveness of tirzepatide in patients with HFpEF using a target trial emulation retrospective cohort study","volume":"16","author":"Lin","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.ekir.2026.106686_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.27258","article-title":"Clinical outcomes of tirzepatide or GLP-1 receptor agonists in individuals with type 2 diabetes","volume":"7","author":"Chuang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ekir.2026.106686_bib20","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1038\/s41467-024-48780-6","article-title":"Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ekir.2026.106686_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.21305","article-title":"Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ekir.2026.106686_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1164\/rccm.202310-1785OC","article-title":"Effectiveness of fludrocortisone Plus hydrocortisone versus hydrocortisone alone in septic shock: a systematic review and network meta-analysis of randomized controlled trials","volume":"209","author":"Teja","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ekir.2026.106686_bib23","article-title":"Association between corticosteroid use and 28-day mortality in septic shock patients with gram-negative bacterial infection: a retrospective study","volume":"10","author":"Dong","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2026.106686_bib24","article-title":"Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis","volume":"6","author":"Pitre","year":"2024","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.ekir.2026.106686_bib25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamainternmed.2023.0258","article-title":"Comparative effectiveness of fludrocortisone and hydrocortisone vs hydrocortisone alone among patients with septic shock","volume":"183","author":"Bosch","year":"2023","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ekir.2026.106686_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106686_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106686_bib28","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106686_bib29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106686_bib30","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2016.14799","article-title":"Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.106686_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106686_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome","volume":"2018","author":"Mihai","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ekir.2026.106686_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/CIRCULATIONAHA.118.034588","article-title":"Uremic toxin indoxyl sulfate promotes pro-inflammatory macrophage activation via the interplay of OATP2B1 and Dll4-Notch signaling","volume":"139","author":"Nakano","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ekir.2026.106686_bib34","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2022.35","article-title":"Metabolic signatures of immune cells in chronic kidney disease","volume":"24","author":"Li","year":"2022","journal-title":"Expert Rev Mol Med"},{"key":"10.1016\/j.ekir.2026.106686_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/jth.13904","article-title":"Chronic kidney disease and bleeding risk in patients at high cardiovascular risk: a cohort study","volume":"16","author":"Ocak","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ekir.2026.106686_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12879-024-09081-x","article-title":"Prevalence and outcomes of chronic comorbid conditions in patients with sepsis in Korea: a nationwide cohort study from 2011 to 2016","volume":"24","author":"Kang","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ekir.2026.106686_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2215\/CJN.03681106","article-title":"Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes","volume":"2","author":"Bagshaw","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106686_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJMra032401","article-title":"Acute renal failure and sepsis","volume":"351","author":"Schrier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.106686_bib39","article-title":"Are corticosteroids in intensive care immunosuppressive? Reflections and hypotheses","volume":"44","author":"Bra\u00efk","year":"2025","journal-title":"Anaesth Crit Care Pain Med"},{"key":"10.1016\/j.ekir.2026.106686_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae235","article-title":"Aging and chronic kidney disease: epidemiology, therapy, management and the role of immunity","volume":"17","author":"Tang","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.106686_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/cells14060441","article-title":"Clinical value of tocilizumab in reducing mortality in refractory septic shock in children with hematologic and non-hematologic diseases","volume":"14","author":"Lee","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ekir.2026.106686_bib42","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3390\/cancers16081512","article-title":"Outcome of tocilizumab treatment in febrile neutropenic children with severe sepsis\/septic shock in a single-center retrospective case series","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ekir.2026.106686_bib43","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1517\/13543784.2011.623125","article-title":"The evolving experience with therapeutic TNF inhibition in sepsis: considering the potential influence of risk of death","volume":"20","author":"Qiu","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ekir.2026.106686_bib44","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S2665-9913(21)00012-6","article-title":"Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study","volume":"3","author":"Cavalli","year":"2021","journal-title":"Lancet Rheumatol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926029189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926029189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:18:34Z","timestamp":1788427114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926029189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2468024926029189"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106686","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrocortisone Use for Septic Shock in Patients With CKD","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106686"}}